Literature DB >> 17684462

Impact of the metabolic syndrome on total arterial compliance in essential hypertension patients.

Giuseppe Mulé1, Emilio Nardi, Santina Cottone, Paola Cusimano, Alessandro Palermo, Francesca Incalcaterra, Maria Ester Giandalia, Giovanni Cerasola.   

Abstract

The aim of the study was to cross-sectionally analyze, in a group of essential hypertension patients without diabetes mellitus, the influence of the metabolic syndrome (MS) on the stroke volume index to pulse pressure (SVi/PP) ratio, a measure of total arterial compliance. A total of 528 essential hypertension patients, aged 18 to 72 years, free from cardiovascular and renal disease (41% of whom had MS) were enrolled. All participants underwent routine blood chemistry, echocardiographic examination, and 3 blood pressure measurements at the end of echocardiographic examination. When compared with participants who did not have MS, hypertensive patients with MS exhibited lower SVi/PP ratio (0.65+/-0.22 vs 0.73+/-0.21 mm Hg; P=.0003). The independent association of MS with SVi/PP ratio (beta=0.10; P=.02) was confirmed in a multivariate regression model including age, sex, and other potential confounders as covariates. The authors' finding may help to explain the enhanced cardiovascular risk associated with MS.

Entities:  

Mesh:

Year:  2007        PMID: 17684462     DOI: 10.1111/j.1559-4564.2007.06006.x

Source DB:  PubMed          Journal:  J Cardiometab Syndr        ISSN: 1559-4564


  7 in total

1.  Role of hyperglycaemia in the pathogenesis of hypotension observed in type-1 diabetic rats.

Authors:  I-Min Liu; Cheng Kuei Chang; Shiow-Wen Juang; Dai-Huang Kou; Yat-Ching Tong; Kai-Chun Cheng; Juei-Tang Cheng
Journal:  Int J Exp Pathol       Date:  2008-08       Impact factor: 1.925

2.  Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications.

Authors:  Richard E Katholi; Daniel M Couri
Journal:  Int J Hypertens       Date:  2011-06-30       Impact factor: 2.420

3.  Central versus peripheral cardiovascular risk in metabolic syndrome.

Authors:  H Edgell; R J Petrella; G J Hodges; J K Shoemaker
Journal:  Front Physiol       Date:  2012-02-27       Impact factor: 4.566

4.  The Association of Left Ventricular Mass Index with Metabolic Syndrome in Comparison to Hypertensive Patients.

Authors:  Rajesh K Gupta; Rimzim Gupta; Neeraj Makar; Shashank Chaudhary; Himanshu Bhatheja; Prashant Pathak
Journal:  J Cardiovasc Echogr       Date:  2016 Apr-Jun

5.  ECG Indices Poorly Predict Left Ventricular Hypertrophy and Are Applicable Only in Individuals With Low Cardiovascular Risk.

Authors:  Małgorzata Chlabicz; Jacek Jamiołkowski; Marlena Paniczko; Paweł Sowa; Małgorzata Szpakowicz; Magda Łapińska; Natalia Jurczuk; Marcin Kondraciuk; Katarzyna Ptaszyńska-Kopczyńska; Andrzej Raczkowski; Anna Szpakowicz; Karol Adam Kamiński
Journal:  J Clin Med       Date:  2020-05-06       Impact factor: 4.241

6.  Gender differences relating to metabolic syndrome and proinflammation in Finnish subjects with elevated blood pressure.

Authors:  Tiina Ahonen; Juha Saltevo; Markku Laakso; Hannu Kautiainen; Esko Kumpusalo; Mauno Vanhala
Journal:  Mediators Inflamm       Date:  2009-08-20       Impact factor: 4.711

7.  QTLs of factors of the metabolic syndrome and echocardiographic phenotypes: the hypertension genetic epidemiology network study.

Authors:  Aldi T Kraja; Pinchia Huang; Weihong Tang; Steven C Hunt; Kari E North; Cora E Lewis; Richard B Devereux; Giovanni de Simone; Donna K Arnett; Treva Rice; D C Rao
Journal:  BMC Med Genet       Date:  2008-11-27       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.